Skip to content

Clinical trials

Completed Observational Hemoglobinopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Phase: Observational Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20152
20161
20171
20191
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco4
National Institute of Allergy and Infectious Diseases (NIAID)3
Bangladesh Bioscience Research Group2
Bacha Khan Medical College1
Columbia University1
Hospital Universitari Vall d'Hebron Research Institute1
Società Italiana Talassemie ed Emoglobinopatie1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies14
Anemia, Sickle Cell8
Thalassemia8
Fanconi Anemia4
Hematologic Neoplasms4
Immunologic Deficiency Syndromes4
Malaria3
COVID-192
beta-Thalassemia2
Anemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.